JWA
AMRX icon

JFS Wealth Advisors’s Amneal Pharmaceuticals AMRX Stock Holding History

JFS Wealth Advisors’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.27K Buy
189
+84
+80% +$1.15K ﹤0.01% 1451
2026
Q1 		$1.31K Buy
105
+1
+1% +$13 ﹤0.01% 1618
2025
Q4 		$1.31K Buy
104
+34
+49% +$389 ﹤0.01% 1659
2025
Q3 		$701 Buy
70
+8
+13% +$72 ﹤0.01% 1693
2025
Q2 		$502 Buy
62
+18
+41% +$136 ﹤0.01% 1696
2025
Q1 		$369 Buy
+44
New +$367 ﹤0.01% 1799
2022
Q4 		– Sell
-15
Closed – – 1949
2022
Q3 		$0 Sell
15
-16
-52% -$45 ﹤0.01% 1724
2022
Q2 		$0 Buy
31
+14
+82% +$51 ﹤0.01% 1718
2022
Q1 		$0 Buy
17
+11
+183% +$49 ﹤0.01% 1807
2021
Q4 		$0 Buy
+6
New +$30 ﹤0.01% 1693

Other funds holding AMRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

JFS Wealth Advisors's AMRX Position: Q2 2026 in Review

JFS Wealth Advisors increased its Amneal Pharmaceuticals (AMRX) stake by 80% in Q2 2026, buying an estimated $1.15K and bringing the position to 189 shares worth $3.27K. The position accounts for ﹤0.01% of the portfolio, ranked #1451.

JFS Wealth Advisors first reported a position in AMRX in Q4 2021 and has held it in 10 quarters since. 306 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

  • JFS Wealth Advisors held 189 shares of Amneal Pharmaceuticals worth $3.27K as of Q2 2026.
  • JFS Wealth Advisors bought 84 Amneal Pharmaceuticals shares in Q2 2026, an estimated $1.15K.
  • Amneal Pharmaceuticals made up ﹤0.01% of JFS Wealth Advisors's portfolio in Q2 2026, its #1451 holding.
  • JFS Wealth Advisors first reported a position in Amneal Pharmaceuticals in Q4 2021 and has held it in 10 quarters since.
  • 306 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on JFS Wealth Advisors's 13F filing for Q2 2026, filed 10 Jul 2026.